Aytu Biopharma Inc (AYTU)

Jun 12, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Jun 12, 2026

Jun 11, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Jun 11, 2026

Jun 11, 2026

AYTU Maintained by Ascendiant Capital -- Price Target Raised to $14.50 - GuruFocus

Jun 11, 2026

Jun 08, 2026

AYTU Q1 2026 Earnings: EPS Misses Estimates Amid Challenging QuarterUpward Estimate Revision - newsline.com

Jun 08, 2026

Jun 06, 2026

Aytu BioPharma Gains 5.89% as Small-Cap Biotech Finds TractionDaily Profile - newsline.com

Jun 06, 2026

Jun 05, 2026

Aytu BioPharma Inc. (AYTU) Gains 3.3% as Shares Approach Resistance at $2.30Channel Breakout - newsline.com

Jun 05, 2026

Jun 01, 2026

Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026 - Hastings Tribune

Jun 01, 2026

May 30, 2026

Aytu BioPharma (AYTU) Edges Higher, Testing Key Resistance ZoneSector ETF Flow - The Legal Advocate

May 30, 2026

May 28, 2026

AYTU Q1 2026 Earnings: EPS Misses Estimates by 1.88%, Stock Declines Amid Sparse DisclosureReturn On Assets - The Legal Advocate

May 28, 2026

May 28, 2026

AYTU: EXXUA’s launch drives growth as legacy ADHD revenues decline, with strong financial footing - TradingView

May 28, 2026

May 27, 2026

AYTU Q1 2026 Earnings: EPS Misses Estimates Amidst Operational ChallengesEarnings Trend Analysis - The Legal Advocate

May 27, 2026

May 27, 2026

AYTU Q1 2026 Earnings EPS Misses Estimates Amidst Operational ChallengesThe Legal Advocate - The Legal Advocate

May 27, 2026

May 27, 2026

Aytu BioPharma (AYTU) Holds Near Support Amid Low-Volume TradingWeak Sell Signals - newsline.com

May 27, 2026

May 25, 2026

Aytu BioPharma Rallies as Shares Test Key Resistance LevelsCumulative Volume - The Legal Advocate

May 25, 2026

May 24, 2026

Aytu BioPharma Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock MovementEarnings Call Highlights - The Legal Advocate

May 24, 2026

May 23, 2026

AYTU Q1 2026 Earnings: EPS Misses Estimates Amid Operational Challenges, Stock Rises SlightlyCFO Commentary Report - newsline.com

May 23, 2026

May 22, 2026

Aytu BioPharma Gains 1.64% as Stock Tests Key Resistance at $2.28ETF Flow - thelegaladvocate.com

May 22, 2026

May 19, 2026

Earnings call transcript: Aytu BioPharma Q3 2026 reveals earnings miss By Investing.com - Investing.com Nigeria

May 19, 2026

May 19, 2026

Earnings call transcript: Aytu BioPharma Q3 2026 reveals earnings miss - Investing.com

May 19, 2026

May 18, 2026

Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 - ACCESS Newswire

May 18, 2026

May 18, 2026

Pharma firm Aytu BioPharma to present at virtual investor event May 28 - Stock Titan

May 18, 2026

May 18, 2026

Aytu outlines $6M-$7M quarterly sales and marketing spend range as EXXUA scripts rise to over 920 in April - MSN

May 18, 2026

May 18, 2026

Aytu BioPharma to Participate in September 2022 Investor Conferences - The Chronicle-Journal

May 18, 2026

May 18, 2026

Aytu BioPharma, Inc.Common Stock (NQ: AYTU - The Chronicle-Journal

May 18, 2026

May 17, 2026

What Aytu Bio AYTU is doing that separates it from the herd Institutional Selling 20260507Dividend Growth Analysis - The Legal Advocate

May 17, 2026

May 17, 2026

Analysts Expect Breakeven For Aytu BioPharma, Inc. (NASDAQ:AYTU) Before Long - Sahm

May 17, 2026

May 15, 2026

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q3 2026 Earnings Call Transcript - Insider Monkey

May 15, 2026

May 14, 2026

AYTU BIOPHARMA INC | BIG RISK REWARD | AYTU STOCK | AYTU BIOPHARMA STOCK (K8VNph4cYO) - fathomjournal.org

May 14, 2026

May 14, 2026

Aytu BioPharma, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance

May 14, 2026

May 14, 2026

Aytu BioPharma Inc (AYTU) Q3 2026 Earnings Call Highlights: Stro - GuruFocus

May 14, 2026

May 13, 2026

Is Aytu BioPharma (AYTU) Overvalued After Q3 FY2026 Earnings Mis - GuruFocus

May 13, 2026

May 13, 2026

Aytu (AYTU) Reports Strong Q3 Revenue and Positive Launch Moment - GuruFocus

May 13, 2026

May 13, 2026

Aytu BioPharma, Inc. (AYTU) reports Q3 loss, tops revenue estimates - MSN

May 13, 2026

May 13, 2026

Aytu BioPharma, Inc. (AYTU) Reports Q3 Loss, Tops Revenue Estimates - sharewise.com

May 13, 2026

May 13, 2026

AYTU: EXXUA's launch drove strong early growth, with over 1,300 prescriptions and $2.4M in revenue - TradingView

May 13, 2026

May 13, 2026

Aytu Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2026

May 13, 2026

Aytu (AYTU) Q3 2026 Earnings Transcript - The Globe and Mail

May 13, 2026

May 13, 2026

Full Transcript: Aytu BioPharma Q3 2026 Earnings Call - Yahoo Finance

May 13, 2026

May 13, 2026

Aytu BioPharma (NASDAQ:AYTU) Surges 23% as EXXUA Launch Gains Early Traction in Mixed Q3 Results - ChartMill

May 13, 2026

May 13, 2026

Aytu BioPharma Q3 revenue falls amid EXXUA launch - TradingView

May 13, 2026

May 13, 2026

Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results - ACCESS Newswire

May 13, 2026

May 13, 2026

AYTU BIOPHARMA Q3 EPS USD -0.53 - Moomoo

May 13, 2026

May 13, 2026

Aytu BioPharma (AYTU) swings to loss while launching EXXUA and cutting warrant liabilities - Stock Titan

May 13, 2026

May 13, 2026

EXXUA launch reshapes Aytu BioPharma (Nasdaq: AYTU) Q3 2026 results - Stock Titan

May 13, 2026

May 12, 2026

MSN Money - MSN

May 12, 2026

May 12, 2026

Aytu BioPharma Q3 Earnings Announcement Scheduled - Intellectia AI

May 12, 2026